Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.

Quotes for Abera Bioscience AB

Right Now

+/-
-0.65
%
-4,08%
Latest
15.3
High
16.05
Low
15.3
Volume
6 746
Turnover (SEK)
104 856
Value (MSEK)
177,1

Board

CEO

  • Maria Alriksson

Chairperson of the Board

  • Anders Ericsson

Board

  • Cristina Glad
  • Fredrik Juserius
  • Joen Luirink

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 10,59 10,59 2021-12-31
Nordnet Pensionsförsäkring 9,68 9,68 2021-12-31
Anders Ericsson 6,12 6,12 2022-01-20
Jan-Willem De Gier 5,16 5,16 2021-12-31
Joen Luirink 5,04 5,04 2021-12-31
Magnus Linderoth 4,97 4,97 2021-12-31
John Moll 4,90 4,90 2021-02-08
Johan Källstrand 3,51 3,51 2021-12-31
Anders Wall Stiftelser 2,77 2,77 2021-12-31
Mårten Hellberg 2,28 2,28 2021-02-08
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-02-23 Bokslutskommuniké 2021